Tyrosine kinase inhibitor‐induced IL‐6/STAT3 activation decreases sensitivity of EGFR‐mutant non‐small cell lung cancer to icotinibJinyao Wang, Xiaofang Che, Tieqiong Zhang et al.|Cell Biology International|2018Cited by 21
Suppressed expression of Cbl‐b by <i>NF‐κB</i> mediates icotinib resistance in EGFR‐mutant non‐small‐cell lung cancerTieqiong Zhang, Xuejun Hu, Chunlei Zheng et al.|Cell Biology International|2018Cited by 10